Integramed America, Inc. (INMD) Tops Q4 EPS by 3c, Sales Top Consensus
Tweet
Share
E-mailGet Alerts INMD Hot Sheet
Price: $14.36 +0.07%
EPS Growth %: -15.8%
Financial Fact:
Total other expenses: 2.95M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: -15.8%
Financial Fact:
Total other expenses: 2.95M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Integramed America, Inc. (NASDAQ: INMD) reported Q4 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $70.88 million versus the consensus estimate of $69.58 million.
For earnings history and earnings-related data on Integramed America, Inc. (INMD) click here.
For earnings history and earnings-related data on Integramed America, Inc. (INMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HP shares slide as tech giant forecasts 2027 PC market slump
- Microchip Technology completes acquisition of Hailo
- Standard Uranium extends private placement closing date to October 18
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
